Trials / Unknown
UnknownNCT03607383
Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Saint-Joseph University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.
Detailed description
Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Studies performed on American and Chinese populations have shown positive results. These studies need confirmation in different populations. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Red Rice Yeast Extract | adults requiring moderate intensity treatment will be provided red rice yeast extracts or statins, depending on the randomization; followed for compliance and adverse effects check, and reevaluated in a final visit with blood test after 8 weeks |
| DRUG | Statin | Statin choice is done at the discretion of the treating physician for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions, for 8 weeks |
Timeline
- Start date
- 2018-02-07
- Primary completion
- 2020-04-30
- Completion
- 2020-04-30
- First posted
- 2018-07-31
- Last updated
- 2019-10-08
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT03607383. Inclusion in this directory is not an endorsement.